Public Resources

Action Brief: Rheumatoid Arthritis_October 2016 

08-04-2017 10:33 AM

Inflammatory conditions such as rheumatoid arthritis (RA) typically rank among the top three most costly conditions for specialty drugs, along with cancer and multiple sclerosis. RA is a chronic, inflammatory autoimmune disease that causes a range of symptoms, including stiffness and swelling in the joints, particularly in the hands, feet and knees. RA is a form of arthritis that is immune mediated and attacks healthy tissue. If left untreated, this condition can cause significant permanent damage to tissues in the joints, often leading to short- or long-term disability, or in some cases, forcing employees to stop working completely.
#PharmacyandMedicalDrugs

Attachment(s)
pdf file
NBCH_ARTHRITIS_NEW_C.pdf   759 KB   1 version
Uploaded - 08-04-2017

Comments

08-08-2017 08:45 PM

"...13% of employees with RA facing some form of disability at six months and up to 67% at 15 years from the onset of RA."  Important for employers to remove barriers to treatment and explore creative return-to-work policies.

Related Entries and Links

No Related Resource entered.